Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 12.93% on an annualized basis producing an average annual return of 20.63%. Currently, Vertex Pharmaceuticals has a market capitalization of $82.90 billion.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 15 years ago, it would be worth $1,644.40 today based on a price of $322.96 for VRTX at the time of writing.
Vertex Pharmaceuticals's Performance Over Last 15 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.